The European POCT Device Market is expected to reach USD 11,682.54 billion by 2024 from USD 6,051.05 billion in 2016. It is expected to grow at a CAGR of 8.6% in the forecast period 2017 to 2024.
Europe Point-of-care Testing (POCT) Market By Product (Blood Glucose Testing Kits, Cardiometabolic Monitoring Kits, Infectious Disease Testing Kits, Cholesterol Testing Kits, Pregnancy & Fertility Tests Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Cholesterol Test Strips, Hematology Testing Kits, Drugs Of Abuse Testing Kits, Fecal Occult Testing Kits, Rapid Coagulation Testing Kits, & Others),By Prescription Mode (Prescription Based Testing & Over-The-Counter Testing),By Distribution Channel (Direct Tenders & Retail),By End User (Hospital, Clinics, Ambulatory Care, Home Healthcare, & Research Laboratory), By Country (Germany, United Kingdom, France, Spain, Italy, Russia, Turkey, Belgium, Nether lands, Switzerland, Rest of Europe) – Trends and Forecast to 2024
Ask for Sample Report Visit @ databridgemarketresearch.com/reque…oct-device-market
The major factors driving the growth of this market are the rising scope of POCT devices, advancement in technology, increasing incidence of chronic diseases, rising demand for self-testing point-of-care testing devices, decentralized laboratory testing, and technological advancements like microfluidic lab on a chip technology. These factors increase the demand for devices such as blood glucose meter, CRP, HBA1C, Homocystein.
On the other hand, high costsare regulatory hurdles that may hinder the growth of the market.
Market Segmentation: Europe POCT Device Market
The Europe POCT device market is segmented on the basis of product type, prescription mode, distribution channel, end userand geography.
Cardiometabolic monitoring kits are further segmented into cardiac markers, blood gas/electrolytes testing kits, HbA1c testing kits, and lipids testing. Also, infectious disease testing kits are further segmented into influenza testing kits, HIV testing kits, hepatitis C testing kits, sexually-transmitted diseases testing kits, tropical diseases testing kits, healthcare-associated infections), and respiratory infections testing kit.
On the basis of prescription mode, the Europe point-of-care testing market is segmented into prescription based testing and over-the-counter (OTC) testing.
On the basis of distribution channel, the Europe point-of-care testing market is segmented into direct tenders and retail.
Enquire about report @ databridgemarketresearch.com/inqui…oct-device-market
On the basis of end users, the Europe point-of-care testing market is segmented into hospital, clinics, ambulatory care, home healthcare, and research laboratory. Hospital segment is further categorized into emergency department critical-care unit, general ward, and others (intensive care unit, neo-natal).
Based on geography, the market is segmented into11 geographical regions, such as Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland and rest of Europe.
Key Drivers: Europe POCT Device Market
Some of the major factors driving the market for rising scope of POCT devices, advancement in technology, increasing incidence of chronic diseases, rising demand for self-testing point-of-care testing devices, decentralized laboratory testing, and technological advancements like microfluidic lab on a chip technology. These factors increase the demand for devices such as blood glucose meter, CRP, HBA1C, Homocystein.
Key Points: Europe POCT Device Market
Some of the major players operating in the Europe POCT Device Market are Abbott Laboratories, Inc. (U.S.), Alere Inc. (U.S.), roche Diagnostics Limited (Switzerland), Siemens AG (Germany), Becton, Dickinson and Company (U.S.), Johnson & Johnson Services Inc.
(U.S.), PTS Diagnostics (U.S.), Instrumentation Laboratory (U.S.), Nova Biomedical (U.S.), Beckman Coulter, Inc. (U.S.) and others.
The Europe point-of-care testing market report contains an in-depth profiling of the key market players, along with the recent developments (new product developments, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their position in the market. For instance, in 2016, Health care giant Abbott Laboratories (U.S.) has acquiredAlere Inc.
(U.S.), a diagnostics-testing company for USD 5.8 billion. The intent was to get access over Alere’s portfolio that would provide a quick diagnoses that would perform speedy test as well as can save the time and cost.
Read more about the Europe POCT Device Market Visit @ databridgemarketresearch.com/repor…ct-device-market/
Category: Market Research Publishers and RetailersCompany about: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...
For more information: